Bluejay Diagnostics Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

2.90M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	249.04K	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
UnitedHealth Group	435.16B
Johnson & Johnson	92.15B
Merck & Co.	64.24B
AbbVie	59.64B
Eli Lilly and Company	59.42B
AstraZeneca	58.13B
Novartis AG	56.37B
Novo Nordisk	49.58B

Revenue Rankings

BJDX News

4 weeks ago - Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
4 weeks ago - Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
4 weeks ago - Bluejay Diagnostics and SanyoSeiko Expand Strategic Partnership to Advance Commercialization of Symphony Platform - GlobeNewsWire
3 months ago - Bluejay Diagnostics Provides Second Quarter Business and Corporate Update - GlobeNewsWire
5 months ago - Bluejay Diagnostics Provides Mid-Year Business and Corporate Update - GlobeNewsWire
7 months ago - Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting - GlobeNewsWire
7 months ago - Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds - GlobeNewsWire
1 year ago - Bluejay Diagnostics Announces Reverse Stock Split - GlobeNewsWire

More News